developmental and epileptic encephalopathy 102

Description

Developmental and Epileptic Encephalopathy (DEE): A Rare and Severe Form of Epilepsy

Developmental and epileptic encephalopathy (DEE) is a rare and severe form of epilepsy that affects individuals, typically beginning in infancy or childhood. This condition is characterized by frequent seizures of multiple types, intellectual disability, and significant developmental delay, regression, or plateau.

Key Features:

  • Seizures: DEEs are marked by frequent seizures of various types, which can be challenging to control with medication.
  • Developmental Delay: Individuals with DEE often experience significant delays in cognitive development, including intellectual disability.
  • Regression or Plateau: In some cases, individuals may experience regression or a plateau in their developmental progress.

Causes and Risk Factors:

While the exact causes of DEE are not fully understood, research suggests that genetic variants play a significant role. Many DEEs are related to gene variants, and the onset is typically during early childhood.

Impact on Neurocognition:

The term "developmental and epileptic encephalopathy" (DEE) refers to when cognitive functions are influenced by both seizure and interictal epileptiform activity and the neurobiological process behind the epilepsy. This highlights the complex relationship between seizures, developmental delay, and neurocognitive function.

Subtypes:

DEEs can be further categorized into subgroups based on age of onset, severity, and other factors. For example, early-infantile DEE is a subgroup where seizures begin before 3 months of age.

Treatment and Management:

While there is no cure for DEE, various treatment options are available to manage symptoms and improve quality of life. These may include medication, surgery, and other interventions tailored to individual needs.

References:

  • [1] Developmental and Epileptic Encephalopathies (DEEs) are a group of rare and severe epilepsies. DEEs commonly begin in infancy or childhood and are associated with frequent seizures of multiple different types, intellectual disability and significant developmental delay, regression or plateau.
  • [2] The term "developmental and epileptic encephalopathy" (DEE) refers to when cognitive functions are influenced by both seizure and interictal epileptiform activity and the neurobiological process behind the epilepsy. Many DEEs are related to gene variants and the onset is typically during early childhood.
  • [3] Developmental and epileptic encephalopathies, the most severe group of epilepsies that feature both seizures and developmental consequences.
  • [4] Early-infantile developmental and epileptic encephalopathy (EIDEE) is a subgroup of DEE, where the onset of seizures is before 3 months of age.

Additional Characteristics

  • intellectual disability
  • Developmental and epileptic encephalopathy (DEE)
  • frequent seizures
  • significant developmental delay
  • regression or plateau
  • genetic variants
  • gene variants
  • early-infantile DEE
  • subtypes of DEEs

Signs and Symptoms

Developmental and Epileptic Encephalopathy (DEE) 102, also known as Early Infantile Epileptic Encephalopathy 4 (EIEE4), is a rare and severe form of epilepsy that affects infants. The signs and symptoms of DEE 102 can vary in severity and may include:

  • Seizures: Frequent seizures are a hallmark of DEE 102, often starting within the first few months of life [10].
  • Developmental delay: Infants with DEE 102 typically experience significant developmental delays, including delayed motor skills, language development, and cognitive abilities [3].
  • Intellectual disability: Many children with DEE 102 develop intellectual disabilities, ranging from mild to severe [11].
  • Reduced muscle tone (hypotonia): Infants with DEE 102 may exhibit reduced muscle tone, making it difficult for them to move or maintain posture [11].
  • Hypsarrhythmia: An irregular pattern seen on EEG is a common feature of DEE 102 [11].
  • Dyskinesia: Involuntary movements of the body can occur in children with DEE 102 [11].

It's essential to note that each child with DEE 102 may experience a unique combination of these symptoms, and their severity can vary widely. Early diagnosis and treatment are crucial for managing the condition and improving outcomes.

References: [3] - Developmental and Epileptic Encephalopathies (DEEs) are a group of rare and severe epilepsies. [10] - These conditions are referred to as Developmental Epileptic Encephalopathies (DEE) to acknowledge the presence of multiple causes for the developmental damages. [11] - Other signs and symptoms may include intellectual disability, reduced muscle tone (hypotonia), hypsarrhythmia (an irregular pattern seen on EEG), dyskinesia (involuntary movement of the body), and spastic di- or quadriplegia.

Additional Symptoms

  • Seizures
  • Intellectual disability
  • Developmental delay
  • Hypsarrhythmia
  • Dyskinesia
  • Reduced muscle tone (hypotonia)

Diagnostic Tests

Diagnostic Tests for Developmental and Epileptic Encephalopathy

Developmental and epileptic encephalopathy (DEE) is a complex condition that requires a comprehensive diagnostic approach. The following tests are commonly used to identify the underlying cause of DEE:

  • Electroencephalogram (EEG): An EEG measures the electrical activity in the brain and can help detect abnormal patterns associated with DEE [8].
  • Magnetic Resonance Imaging (MRI): MRI scans can be useful in identifying structural abnormalities or lesions that may contribute to DEE. Molecular testing can also facilitate diagnosis of the underlying cause [7].
  • Chromosomal Microarray Analysis (CMA): CMA is a powerful tool for detecting clinically significant genomic variants, such as microdeletions and duplications, which can be associated with DEE [5].
  • Next-Generation Sequencing (NGS): NGS using a panel of up to 500 genes can help identify the underlying genetic cause of DEE [6].
  • Genetic testing: Genetic testing is very useful in the differential diagnosis of hereditary epileptic encephalopathies. Prenatal diagnosis is also possible in some cases [9].

These diagnostic tests are essential for identifying the underlying cause of DEE, which can inform treatment decisions and improve prognosis. Early diagnosis and intervention can lead to better outcomes and potentially reverse developmental slowing [10][11].

Additional Diagnostic Tests

  • Magnetic Resonance Imaging (MRI)
  • Genetic testing
  • Next-Generation Sequencing (NGS)
  • Electroencephalogram (EEG)
  • Chromosomal Microarray Analysis (CMA)

Treatment

Treatment Options for Developmental and Epileptic Encephalopathy

Developmental and epileptic encephalopathies (DEEs) are a group of severe epilepsies that can be challenging to manage. While there is no cure for DEEs, various treatment options are available to help control seizures and improve quality of life.

  • Medications: Antiepileptic drugs (AEDs) are the first line of treatment for DEEs. However, due to the severe nature of these conditions, many patients experience poor response to AEDs [1]. In such cases, alternative medications or combinations of medications may be considered.
  • Surgical Interventions: In some cases, surgical options like corpus callosotomy or hemispherectomy may be considered for patients with DEEs who have severe and intractable seizures [7].
  • Vagus Nerve Stimulation (VNS): VNS is a treatment option that involves implanting a device that stimulates the vagus nerve to help reduce seizure frequency. While it has shown promise, its effectiveness can vary from person to person [6].
  • Dietary Therapies: Some patients with DEEs may benefit from dietary therapies like the ketogenic diet or modified Atkins diet, which involve making specific changes to their eating habits to help control seizures [5].

It's essential to note that each patient with DEE is unique, and treatment plans should be tailored to individual needs. A multidisciplinary team of healthcare professionals, including neurologists, epileptologists, and other specialists, can work together to develop a comprehensive treatment plan.

References:

[1] CJ Landmark (2021) - Developmental and Epileptic Encephalopathies: A Review of the Literature [2] [7] Jul 26, 2022 - Early Infantile Epileptic Encephalopathy (Ohtahara Syndrome) [5] Epileptic encephalopathies are an epileptic condition characterized by early-onset seizures. Learn everything you need to know at CHOC.org. [6] ACH Ng (2024) - Abstract. Patients with epileptic encephalopathy with spike wave activation in sleep (EE-SWAS) [9] GJ Sills (2023) - Developmental and Epileptic Encephalopathies (DEEs): A Rare Neurodevelopmental Disorder

Recommended Medications

  • Medications
  • Vagus Nerve Stimulation (VNS)
  • Surgical Interventions
  • Dietary Therapies

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Differential Diagnoses for Developmental and Epileptic Encephalopathy

Developmental and epileptic encephalopathy (DEE) is a complex condition that requires accurate diagnosis to determine the underlying cause. The differential diagnoses for DEE include:

  • Early Myoclonic Encephalopathy: This condition is characterized by early onset seizures, developmental delay, and myoclonic jerks [7].
  • West Syndrome: Also known as infantile spasms, this condition is a severe form of epilepsy that affects infants and young children, often accompanied by developmental delays [7].
  • Other Epileptic Encephalopathies: These include conditions such as Othahara syndrome, Lennox-Gastaut syndrome, and Landau-Kleffner syndrome, which are characterized by distinct EEG patterns and seizure types [7].

Key Diagnostic Features

The diagnosis of DEE is based on a combination of clinical features, including:

  • Developmental Delay: Children with DEE often exhibit significant delays in cognitive, motor, and language development [3].
  • Seizures: Frequent seizures are a hallmark of DEE, often accompanied by abnormal EEG patterns [2].
  • EEG Abnormalities: The electroencephalogram (EEG) is a crucial diagnostic tool for DEE, showing diffuse slowing of the background and frequent seizure discharges [2].

Diagnostic Stages

The diagnosis of DEE occurs in three stages:

  1. Identification of Clinical Features: This stage involves assessing the child's developmental status, seizure frequency, and EEG abnormalities.
  2. Genetic Evaluation: Genetic testing may be performed to identify underlying genetic mutations that contribute to DEE.
  3. Imaging Studies: Imaging studies such as MRI or CT scans may be conducted to rule out other conditions that may mimic DEE.

References

[1] Jul 26, 2022 — Differential Diagnoses · Abnormal Neonatal EEG · Absence Seizures · Acquired Epileptic Aphasia · Aphasia · Autism Spectrum Disorder · Benign Childhood ...

[2] The electroencephalographs (EEGs) in children with DEEs are typically very abnormal, showing diffuse slowing of the background, and frequent seizure discharges.

[3] GRIN2B-related neurodevelopmental disorder is characterized by mild to profound developmental delay / intellectual disability (DD/ID) in all affected ...

[4] by EG Yozawitz — Developmental and epileptic encephalopathy is an epilepsy syndrome diagnosis in individuals whose developmental impairment occurs directly from their presumed ...

[5] Diagnosis. Rates of Status Epilepticus and Sudden Unexplained Death in Epilepsy in People With Genetic Developmental and Epileptic Encephalopathies.

[6] Aug 2, 2022 — Diagnosing an infant with EIDEE syndrome is based on signs and symptoms. It is also based on the baby's EEG results, which is the most important ...

[7] Differential diagnoses include other epileptic encephalopathies such as early myoclonic encephalopathy, West syndrome (see these terms) and other early onset ...

[8] Diagnosis of epileptic encephalopathies occurs in three stages that work together to inform treatment planning. The diagnostic stages include identification of ...

[9] by TT Sands · 2024 · Cited by 2 — An underlying etiology drives developmental outcomes directly (developmental encephalopathy) and also results in epilepsy. The abnormal ...

[10] Jul 15, 2022 — We divide on the science, but we unite on everything else as it relates to the developmental and epileptic encephalopathy including Dravet, ...

Additional Information

oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:0070388
core#notation
DOID:0070388
oboInOwl#hasDbXref
MIM:619881
oboInOwl#hasExactSynonym
early infantile epileptic encephalopathy 102
rdf-schema#label
developmental and epileptic encephalopathy 102
IAO_0000115
A developmental and epileptic encephalopathy characterized by global developmental delay and severe to profoundly impaired intellectual development with inability to walk or speak that has_material_basis_in homozygous or compound heterozygous mutations in the SLC38A3 gene on chromosome 3p21.
rdf-schema#subClassOf
t349542
IDO_0000664
http://purl.obolibrary.org/obo/GENO_0000148
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_2260
owl#annotatedSource
t349835

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.